The field of cardiac safety employs clinical, statistical, and regulatory sciences during the preclinical and clinical development program of a noncardiac drug to prospectively exclude …
Counterfeit medicine has been a subject of much concern for as long as the health and pharmaceutical sector has been established. Counterfeit drugs are a …
For the past 20 years, biotechnology medicines have aided those suffering from chronic conditions, including cancer, diabetes, and auto-immune diseases such as multiple sclerosis and …
Sterile services departments must ensure the consistent supply of sterilised tools and equipment throughout the hospital, and failure or delay can be distressing or dangerous. …
Socio-economic pressure as well as increasingly strong competition have clearly made the entire healthcare industry focus a lot of attention on reducing costs. Not so …
Insulin is only one member of a family of peptide hormones and growth factors that comprises 10 members in humans: insulin, insulin-like growth factors I …
Every product for consumption, ingestion, injection, or cosmetic use must be safe for use and be in perfect condition when used. Micro- organisms, toxic substances …
Patient recruitment challenges the drug development process for a number of reasons. Elio Evangelista at Cutting Edge Information discusses why the increased demand for clinical …
Personalised Medicine Inventions – Is Patent Protection Possible? A recent decision from the US Supreme Court now questions whether patent protection for personalised medicine and …
Biobanks are increasingly playing an important role in biotechnology, pharmaceutical and medical research. John Boother at Autoscribe Ltd looks into why the ability to manage …
IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative
